title: Post-Surgical and Oncologic Outcomes of Supracricoid Partial Laryngectomy: A Single-Institution Report of Ninety Cases.
abstract: OBJECTIVE
  The aim of this study was to report the post-surgical and oncologic outcomes of patients who underwent supracricoid partial laryngectomy (SCPL).
  
  
  METHODS
  90 patients who underwent SCPL between 1994 and 2014 were reviewed. 45 patients underwent cricohyoidopexy (CHP) and 45 patients cricohyoidoepiglottopexy (CHEP). Median nasogastric (NG) tube removal time, decannulation time, overall survival, disease-free survival and local control rates were calculated. The effect of the type of surgery on functional and oncologic outcomes were assessed.
  
  
  RESULTS
  Median NG tube removal time was 16.5 days (IQR = 10) and 14 days (IQR = 9) in CHP and CHEP patients, respectively (p > 0.05). Median decannulation time was 30 days (IQR = 26) and 19 days (IQR = 15) in CHP and CHEP patients, respectively (p < 0.05). Resection of one arytenoid significantly increased NG tube removal time. Median follow-up time was 55 months. There were 15 oncologic failures and the median time interval for tumor recurrence was 9 months. Five-year overall survival rate was 80.4%. The 3- and 5-year disease-free specific survival rates were 81.7 and 76.7%, respectively.
  
  
  CONCLUSIONS
  Given the more extensive surgery applied for CHP, functional outcomes were better in patients with CHEP. Resection of an arytenoid had a negative outcome on swallowing.
authors.affiliation: Department of Otolaryngology, Ege University School of Medicine, Izmir, Turkey.
authors.forename: Kerem
authors.initials: K
authors.lastname: Ozturk
authors.forename: Serdar
authors.initials: S
authors.lastname: Akyildiz
authors.forename: Sercan
authors.initials: S
authors.lastname: Gode
authors.forename: Goksel
authors.initials: G
authors.lastname: Turhal
authors.forename: Tayfun
authors.initials: T
authors.lastname: Kirazli
authors.forename: Abdulhalim
authors.initials: A
authors.lastname: Aysel
authors.forename: Umit
authors.initials: U
authors.lastname: Uluoz
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D003413:Cricoid Cartilage / Q000000981:diagnostic imaging / Q000601:surgery*; D003679:Deglutition; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D007828:Laryngoscopy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D011184:Postoperative Period; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology; D014833:Voice Quality